49 Comparing molecular diagnostic using In-house reflex testing and Next-Generation Sequencing (NGS), A cancer alliance experience in Non-small cell lung cancer (NSCLC)

Genomic testing is standard of care for newly diagnosed NSCLC patients. Gold standard NGS is commissioned but concerns exist around turnaround time (TAT) and failure rate. Rapid turnaround PCR based technology might be a suitable adjunct in delivering a clinical service. In our centre, an inhouse strategy has been developed which is detailed in the methods.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Diagnosis and Staging Source Type: research